Sabby Management’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Sabby Management’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-350,000	Closed	-$161K	–	186
2021 Q1	$161K	Buy	+350,000	New	+$226K	0.03%	141

Other funds holding RVPHW

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Walleye Trading

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Sabby Management's RVPHW Position: Q2 2021 in Review

Sabby Management sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q2 2021, closing a stake of 350,000 shares — an estimated $161K sold.

Sabby Management first reported a position in RVPHW in Q1 2021 and held it in 1 quarter. The position peaked at $161K in Q1 2021. 10 funds tracked by Wall St. Rank hold RVPHW as of Q2 2021.

Sabby Management reported no remaining Reviva Pharmaceuticals Warrants position as of Q2 2021 after selling out during the quarter.
Sabby Management sold 350,000 Reviva Pharmaceuticals Warrants shares in Q2 2021, an estimated $161K.
Sabby Management first reported a position in Reviva Pharmaceuticals Warrants in Q1 2021 and held it in 1 quarter.
Sabby Management's Reviva Pharmaceuticals Warrants position peaked at $161K in Q1 2021.
10 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q2 2021.

Based on Sabby Management's 13F filing for Q2 2021, filed 16 Aug 2021.